Published February 2009 | Version v1
Journal article

Impact of homologous recombination on individual cellular radiosensitivity

  • 1. Centre of Oncology, University Medical Center Hamburg-Eppendorf (Germany)

Description

Purpose: Individual radiosensitivity as measured with in vitro irradiated lymphocytes using metaphase analysis can predict the risk of normal tissue effects after radiotherapy. This parameter is considered to be primarily determined by the cellular repair capacity of DNA double-strand breaks (DSBs). It is now tested to which extent this capacity also depends on homologous recombination (HR), which is a pathway available when cells are in S/G2 phase. Methods: Experiments were performed with CHO K1 cells, in which HR was suppressed via knock-down of RAD51 using RNA interference (RNAi). RAD51 was measured via western and foci formation, cell survival by colony forming, DSBs by γH2AX foci formation, and chromosomal damage using PCC, G0 or G2 assay. Results: In quiescent G1 cells DSB repair is completed 6 h after irradiation. But there is still a substantial fraction of non-repaired DSBs. Most of these DSBs are repaired when G1 cells are stimulated into cell cycle. Suppression of HR by down-regulation of RAD51 did not affect this repair. In contrast, repair was inhibited when cells were irradiated in late S/G2. In line with these data down-regulation of HR did affect survival of cells irradiated in late S/G2, but not in G1. Conclusions: Individual radiosensitivity as measured for G0/1 cells using metaphase analysis does not depend on homologous recombination

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2008.07.028

Additional details

Identifiers

DOI
10.1016/j.radonc.2008.07.028;
PII
S0167-8140(08)00395-2;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
90
Journal Issue
2
Journal Page Range
p. 265-272
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.